MBRX Message Board Post 9267548 | Moleculin Biotech Inc.
home / stock / mbrx / mbrx message board
Admilne
(investorshub)
Posted on: Feb/02/2021 21:41:17
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=161437203
I sold out right after Waiting for this to
News, Short Squeeze, Breakout and More Instantly...
-
Moleculin Completes End of Phase 2 Meeting with FDA for Annamycin in AML PR Newswire HOUSTON , July 10, 2024 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfoli...
-
2024-06-17 10:10:00 ET June 17, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the first of a two-part series looking at developments for the treatment of blood cancers. Today's snapshot focuses in on acute myeloid leukemia (AML) and the compan...
-
Moleculin Announces Additional Positive Preliminary Interim Data from AML Clinical Trial PR Newswire – 89% of CRc's were subjects with "poor prognosis" cytogenetics and/or mutations – Current median durability of response (mDOR) of CRc's = 6 months and in...